Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview.

Miettinen MM, Antonescu CR, Fletcher CDM, Kim A, Lazar AJ, Quezado MM, Reilly KM, Stemmer-Rachamimov A, Stewart DR, Viskochil D, Widemann B, Perry A.

Hum Pathol. 2017 Sep;67:1-10. doi: 10.1016/j.humpath.2017.05.010. Epub 2017 May 24. Review.

2.

Malignant peripheral nerve sheath tumor (MPNST) arising in diffuse-type neurofibroma: clinicopathologic characterization in a series of 9 cases.

Schaefer IM, Fletcher CD.

Am J Surg Pathol. 2015 Sep;39(9):1234-41. doi: 10.1097/PAS.0000000000000447.

PMID:
25929351
3.

Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma.

Naber U, Friedrich RE, Glatzel M, Mautner VF, Hagel C.

J Neurooncol. 2011 Jun;103(2):239-45. doi: 10.1007/s11060-010-0385-4. Epub 2010 Sep 7.

PMID:
20821344
5.

Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.

Beert E, Brems H, Daniëls B, De Wever I, Van Calenbergh F, Schoenaers J, Debiec-Rychter M, Gevaert O, De Raedt T, Van Den Bruel A, de Ravel T, Cichowski K, Kluwe L, Mautner V, Sciot R, Legius E.

Genes Chromosomes Cancer. 2011 Dec;50(12):1021-32. doi: 10.1002/gcc.20921. Epub 2011 Aug 24.

PMID:
21987445
6.

Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.

Longo JF, Weber SM, Turner-Ivey BP, Carroll SL.

Adv Anat Pathol. 2018 Sep;25(5):353-368. doi: 10.1097/PAP.0000000000000197. Review.

PMID:
29762158
7.

Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: Correlating histological and genomic findings.

Carrió M, Gel B, Terribas E, Zucchiatti AC, Moliné T, Rosas I, Teulé Á, Ramón Y Cajal S, López-Gutiérrez JC, Blanco I, Castellanos E, Lázaro C, Stemmer-Rachamimov A, Romagosa C, Serra E.

Hum Mutat. 2018 Aug;39(8):1112-1125. doi: 10.1002/humu.23552. Epub 2018 May 25.

PMID:
29774626
8.

Methylation-based classification of benign and malignant peripheral nerve sheath tumors.

Röhrich M, Koelsche C, Schrimpf D, Capper D, Sahm F, Kratz A, Reuss J, Hovestadt V, Jones DT, Bewerunge-Hudler M, Becker A, Weis J, Mawrin C, Mittelbronn M, Perry A, Mautner VF, Mechtersheimer G, Hartmann C, Okuducu AF, Arp M, Seiz-Rosenhagen M, Hänggi D, Heim S, Paulus W, Schittenhelm J, Ahmadi R, Herold-Mende C, Unterberg A, Pfister SM, von Deimling A, Reuss DE.

Acta Neuropathol. 2016 Jun;131(6):877-87. doi: 10.1007/s00401-016-1540-6. Epub 2016 Feb 8.

PMID:
26857854
9.

Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.

Woodruff JM.

Am J Med Genet. 1999 Mar 26;89(1):23-30. Review.

PMID:
10469433
10.
11.

Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.

Cleven AH, Sannaa GA, Briaire-de Bruijn I, Ingram DR, van de Rijn M, Rubin BP, de Vries MW, Watson KL, Torres KE, Wang WL, van Duinen SG, Hogendoorn PC, Lazar AJ, Bovée JV.

Mod Pathol. 2016 Jun;29(6):582-90. doi: 10.1038/modpathol.2016.45. Epub 2016 Mar 18. Erratum in: Mod Pathol. 2016 Sep;29(9):1113.

12.
13.

Malignant Peripheral Nerve Sheath Tumor.

James AW, Shurell E, Singh A, Dry SM, Eilber FC.

Surg Oncol Clin N Am. 2016 Oct;25(4):789-802. doi: 10.1016/j.soc.2016.05.009. Review.

PMID:
27591499
14.

Superficial malignant peripheral nerve sheath tumor arising from diffuse neurofibroma in a neurofibromatosis type 1 patient.

Inoue T, Kuwashiro M, Misago N, Narisawa Y.

J Dermatol. 2014 Jul;41(7):631-3. doi: 10.1111/1346-8138.12536. Epub 2014 Jun 18.

PMID:
24942776
15.

Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.

Holtkamp N, Mautner VF, Friedrich RE, Harder A, Hartmann C, Theallier-Janko A, Hoffmann KT, von Deimling A.

Acta Neuropathol. 2004 Feb;107(2):159-68. Epub 2003 Dec 13.

PMID:
14673600
16.

Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.

Nielsen GP, Stemmer-Rachamimov AO, Ino Y, Moller MB, Rosenberg AE, Louis DN.

Am J Pathol. 1999 Dec;155(6):1879-84.

17.

Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.

Kazmi SJ, Byer SJ, Eckert JM, Turk AN, Huijbregts RP, Brossier NM, Grizzle WE, Mikhail FM, Roth KA, Carroll SL.

Am J Pathol. 2013 Mar;182(3):646-67. doi: 10.1016/j.ajpath.2012.11.017. Epub 2013 Jan 13.

18.
19.

CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration.

Riddle ND, Gorden L, Rojiani MV, Hakam A, Rojiani AM.

Int J Clin Exp Pathol. 2010 Jun 12;3(5):515-21.

20.

Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors.

Sohier P, Luscan A, Lloyd A, Ashelford K, Laurendeau I, Briand-Suleau A, Vidaud D, Ortonne N, Pasmant E, Upadhyaya M.

Genes Chromosomes Cancer. 2017 May;56(5):421-426. doi: 10.1002/gcc.22446. Epub 2017 Mar 7.

PMID:
28124441

Supplemental Content

Support Center